Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Is a |
Benzoyl peroxide + clindamycin phosphate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzoyl peroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
phosphate de clindamycine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Is a |
Benzoyl peroxide- and clindamycin-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzoyl peroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Clindamycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has manufactured dose form |
Gel (basic dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Is a |
Product containing benzoyl peroxide in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has manufactured dose form |
Conventional release cutaneous gel (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Is a |
Topical clindamycin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
Clindamycin (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has precise active ingredient |
phosphate de clindamycine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
Benzoyl peroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength numerator value |
50 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength numerator value |
dix |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has precise active ingredient |
Benzoyl peroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Is a |
Benzoyl peroxide and clindamycin only product in cutaneous dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|